Search Results 151-160 of 13157 for pharmacogenetics
The purpose of this study is to explore the impact of Setmelanotide on obesity in patients with various specific rare genetic mutations. Participation ...
... pharmacogenetics). His research champions ethnic and racial diversity to improve inclusion in genetic studies focused on understanding health disparities ...
John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in ...
The research will explore how environmental exposures interact with genetics to affect people's responses to medications — a field known as pharmacoexposomics.
Science Saturday: Mayo researchers streamline genetic testing in heart failure clinic, improve clinical care - Mayo Clinic News Network Skip to Navigation --> ...
The purpose of this study approach aims to identify exomic alterations that contribute to the development of kidney disease. Participation eligibility.
About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...
"Dr. Dhamija was very helpful to me. She's the only one ever agree to run the test. We found something big. I have mitochondrial disease that has.
About this study. This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of ...
Dasburg Professor in Cancer Genomics Research at Mayo Clinic in Rochester. He is a pioneer in pharmacogenetics, and his continuing translational work in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Last chance! Your gift today has 5X the power to fuel medical progress using AI.